Sinus Tissue Resection Devices Global Market Report 2025

The sinus tissue resection devices market size has grown strongly in recent years. It will grow from $1.1 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The increase observed in the past period can be linked to the rising number of outpatient ENT surgeries, frequent recurrence of sinus infections necessitating multiple interventions, the impact of urban pollution on respiratory and sinus health, a surge in smoking and tobacco use, and climate changes that affect sinus wellbeing.

The sinus tissue resection devices market size is expected to see strong growth in the next few years. It will grow to $1.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. This projected expansion is driven by the increasing prevalence of chronic sinusitis and rhinosinusitis, a higher occurrence of allergic rhinitis and nasal polyps, growth in ENT surgical procedures worldwide, an aging demographic, and greater awareness regarding sinus-related health issues. Key trends in the coming years include advancements in endoscopic sinus surgery techniques, the development of image-guided navigation technologies, the miniaturization of surgical instruments for enhanced precision, the integration of robotics in ENT surgeries, and improvements in the safety and accuracy of powered devices.

The rising prevalence of chronic sinusitis is expected to significantly contribute to the growth of the sinus tissue resection devices market. Chronic sinusitis, characterized by inflammation of the sinuses lasting over 12 weeks, causes symptoms like nasal congestion, facial pain, and diminished sense of smell. This increase in cases is largely due to environmental allergens such as pollen and pollution, which trigger inflammation and hinder complete recovery, resulting in prolonged sinus infections. Sinus tissue resection devices help by precisely removing obstructive tissue, improving sinus drainage, reducing inflammation, and alleviating symptoms while preventing recurring infections. For example, in December 2023, TGH Urgent Care powered by Fast Track reported that nearly 29 million adults in the United States, or 11.6% of the adult population, suffered from sinusitis, making it a common cause for physician visits. Hence, the growing incidence of chronic sinusitis is expected to drive market growth.

Leading companies in the sinus tissue resection devices market are developing innovative solutions such as single-use ENT instruments to improve procedural efficiency and accessibility in ENT care with portable, minimally invasive surgical tools. Single-use ear, nose, and throat instruments are sterile, disposable tools designed for one-time use during diagnostic or surgical procedures, ensuring patient safety, minimizing infection risks, and removing the need for reprocessing. For instance, in March 2024, Olympus Canada launched the CELERIS Single-Use Sinus Debrider and Celon Elite, including the Celon ProBreath, thereby expanding its ENT product range. The CELERIS system’s unique single-use design includes features like a bendable tip that enhances precision and reduces the need to switch instruments during procedures. This launch offers healthcare providers an efficient and cost-effective option for treating common ENT conditions, such as sinusitis, especially in outpatient settings without requiring costly operating room resources.

In May 2022, Medtronic Plc, an Ireland-based medical technology company, acquired Intersect ENT for $1.1 billion, marking a strategic effort to broaden its portfolio by integrating Intersect ENT’s expertise. Intersect ENT, a US-based healthcare equipment firm, specializes in drug-delivery devices used by ENT clinicians to treat sinusitis. This acquisition strengthens Medtronic’s position in sinus treatment by offering innovative products that improve post-operative outcomes and manage nasal polyps effectively.

Major players in the sinus tissue resection devices market are Johnson & Johnson, Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Smith & Nephew plc, Cook Medical, Karl Storz GmbH & Co. KG, Integra LifeSciences Holdings Corporation, Meril Life Sciences Pvt. Ltd., Summit Medical Inc., PENTAX Medical, Bien-Air, STILLE AB, Entellus Medical Inc., Osteogenics Biomedical Inc., ClaroNav Kolahi Inc., Millennium Surgical Corp., Sinusys Corporation, Spiggle & Theis Medizintechnik GmbH, Hemostasis LLC, Beijing VCA Laser Technology Co. Ltd., and InAccel Technologies Pvt. Ltd.

North America was the largest region in the sinus tissue resection devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sinus tissue resection devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sinus tissue resection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sinus tissue resection devices are specialized medical tools designed to help remove diseased or obstructive tissue from the sinus cavities. They are crafted to offer precision and control during tissue removal, allowing healthcare professionals to accurately target and excise problematic tissue while minimizing harm to surrounding areas.

The main types of sinus tissue resection devices include powered instruments, handheld instruments, endoscopic instruments, and others. Powered instruments in sinus tissue resection devices are electrically or pneumatically operated surgical tools made to precisely cut, remove, or debride soft or hard tissue during sinus operations, improving surgical accuracy and efficiency. These devices are distributed through various channels, such as direct sales, distributors, online retailers, hospital procurement departments, and specialized medical supply companies. Their applications include sinus surgery, nasal polypectomy, treatment of chronic sinusitis, septoplasty, among others. They are used by end-users like hospitals, specialty clinics, ambulatory surgical centers, and more.

The sinus tissue resection devices market research report is one of a series of new reports that provides sinus tissue resection devices market statistics, including sinus tissue resection devices industry global market size, regional shares, competitors with a sinus tissue resection devices market share, detailed sinus tissue resection devices market segments, market trends and opportunities, and any further data you may need to thrive in the sinus tissue resection devices industry. This sinus tissue resection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sinus tissue resection devices market consists of sales of products such as surgical shavers, sinus dilation devices, sinus irrigation systems, surgical knives, and tissue ablation devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.